House Bill 3324 narrows when a physician or health care facility can be treated as a “manufacturer, distributor, seller or lessor” of a product in an Oregon product liability civil action. Under the bill, if a product is supplied to a patient as part of a medical procedure and the physician or facility did not participate in the product’s design or manufacture, that provider is not considered a product seller for purposes of Oregon’s product liability statutes.
The bill also makes the change apply retroactively to claims arising before, on, or after the effective date, with one exception: it does not reopen cases that already have a final judgment. A final judgment is defined as one where appeal rights have expired or no further review is available. In practical terms, the measure would limit product liability exposure for medical providers that merely use or supply a product in treatment rather than create or market it.
Impact
HB 3324 would amend ORS 30.902 within Oregon’s product liability framework (ORS 30.900 to 30.920) to clarify that physicians and health care facilities are not treated as product manufacturers, distributors, sellers, or lessors when they provide a product during a medical procedure without being involved in its design or manufacture. This would likely reduce the ability of plaintiffs to bring product liability claims against hospitals, clinics, and physicians based solely on their role in using or supplying a medical product, shifting potential liability toward actual product designers and manufacturers. The bill’s retroactive application could also affect pending and future claims, subject to the final-judgment limitation.
Sentiment
The available record shows no committee transcripts or recorded votes, so there is no documented floor or committee debate to gauge formal support or opposition. Based on the bill text, the measure appears to be framed as a liability-clarification bill intended to protect health care providers from being treated as product sellers when they are not responsible for the product’s design or manufacture. The absence of recorded opposition or amendments in the provided materials suggests no visible controversy in the available history, though the retroactive application could be significant for litigants.
Contention
The main potential point of contention is whether health care facilities and physicians should receive broad protection from product liability claims when they provide products during medical procedures. Supporters would likely argue the bill prevents misdirected lawsuits against providers who did not design or make the product, while critics could argue it limits injured patients’ avenues for recovery and may shield providers in cases involving defective medical devices or products. The retroactive application is another likely issue, because it could alter the legal landscape for existing claims, although the bill preserves final judgments already entered.